236 related articles for article (PubMed ID: 32303611)
1. Development and validation of the immune signature to predict distant metastasis in patients with nasopharyngeal carcinoma.
Liu SL; Bian LJ; Liu ZX; Chen QY; Sun XS; Sun R; Luo DH; Li XY; Xiao BB; Yan JJ; Lu ZJ; Yan SM; Yuan L; Tang LQ; Li JM; Mai HQ
J Immunother Cancer; 2020 Apr; 8(1):. PubMed ID: 32303611
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of a gene expression-based signature to predict distant metastasis in locoregionally advanced nasopharyngeal carcinoma: a retrospective, multicentre, cohort study.
Tang XR; Li YQ; Liang SB; Jiang W; Liu F; Ge WX; Tang LL; Mao YP; He QM; Yang XJ; Zhang Y; Wen X; Zhang J; Wang YQ; Zhang PP; Sun Y; Yun JP; Zeng J; Li L; Liu LZ; Liu N; Ma J
Lancet Oncol; 2018 Mar; 19(3):382-393. PubMed ID: 29428165
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of a transcriptomics-based gene signature to predict distant metastasis and guide induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma.
Liu SL; Sun XS; Chen QY; Liu ZX; Bian LJ; Yuan L; Xiao BB; Lu ZJ; Li XY; Yan JJ; Yan SM; Li JM; Bei JX; Mai HQ; Tang LQ
Eur J Cancer; 2022 Mar; 163():26-34. PubMed ID: 35032814
[TBL] [Abstract][Full Text] [Related]
4. Plasma protein-based signature predicts distant metastasis and induction chemotherapy benefit in Nasopharyngeal Carcinoma.
Liang Y; Li J; Li Q; Tang L; Chen L; Mao Y; He Q; Yang X; Lei Y; Hong X; Zhao Y; He S; Guo Y; Wang Y; Zhang P; Liu N; Li Y; Ma J
Theranostics; 2020; 10(21):9767-9778. PubMed ID: 32863958
[No Abstract] [Full Text] [Related]
5. Development and validation of a magnetic resonance imaging-based model for the prediction of distant metastasis before initial treatment of nasopharyngeal carcinoma: A retrospective cohort study.
Zhang L; Dong D; Li H; Tian J; Ouyang F; Mo X; Zhang B; Luo X; Lian Z; Pei S; Dong Y; Huang W; Liang C; Liu J; Zhang S
EBioMedicine; 2019 Feb; 40():327-335. PubMed ID: 30642750
[TBL] [Abstract][Full Text] [Related]
6. Individualized induction chemotherapy by pre-treatment plasma Epstein-Barr viral DNA in advanced nasopharyngeal carcinoma.
Zhang J; Peng H; Li WF; Zhang Y; Liu LZ; Tian L; Lin AH; Sun Y; Ma J
BMC Cancer; 2018 Dec; 18(1):1276. PubMed ID: 30567511
[TBL] [Abstract][Full Text] [Related]
7. Induction chemotherapy plus IMRT alone versus induction chemotherapy plus IMRT-based concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: a retrospective cohort study.
Wei Z; Zhang Z; Luo J; Li N; Peng X
J Cancer Res Clin Oncol; 2019 Jul; 145(7):1857-1864. PubMed ID: 31062162
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of an immune checkpoint-based signature to predict prognosis in nasopharyngeal carcinoma using computational pathology analysis.
Wang YQ; Zhang Y; Jiang W; Chen YP; Xu SY; Liu N; Zhao Y; Li L; Lei Y; Hong XH; Liang YL; Li JY; Zhang LL; Yun JP; Sun Y; Li YQ; Ma J
J Immunother Cancer; 2019 Nov; 7(1):298. PubMed ID: 31722750
[TBL] [Abstract][Full Text] [Related]
9. CD3+T-lymphocyte infiltration is an independent prognostic factor for advanced nasopharyngeal carcinoma.
Al-Rajhi N; Soudy H; Ahmed SA; Elhassan T; Mohammed SF; Khoja HA; Ghebeh H
BMC Cancer; 2020 Mar; 20(1):240. PubMed ID: 32199452
[TBL] [Abstract][Full Text] [Related]
10. The efficacy and safety of docetaxel, cisplatin and fluorouracil (TPF)-based induction chemotherapy followed by concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: a meta-analysis.
Zhou R; Zhu J; Chen X; Liu Y; Wang Y; Zhang T
Clin Transl Oncol; 2020 Mar; 22(3):429-439. PubMed ID: 31165410
[TBL] [Abstract][Full Text] [Related]
11. A Four-Gene Signature Model Improves the Prediction of Distant Metastasis in Patients with Nasopharyngeal Carcinoma: A Retrospective, Three-Center Observational Study.
Si J; Ding X; Deng Z; Li P; Zhang B; Lan G; Huang B; Liang J; Wang Z; Si Y
Technol Cancer Res Treat; 2022; 21():15330338221080972. PubMed ID: 35262435
[No Abstract] [Full Text] [Related]
12. Development and external validation of nomograms to predict the risk of skeletal metastasis at the time of diagnosis and skeletal metastasis-free survival in nasopharyngeal carcinoma.
Yang L; Xia L; Wang Y; He S; Chen H; Liang S; Peng P; Hong S; Chen Y
BMC Cancer; 2017 Sep; 17(1):628. PubMed ID: 28874126
[TBL] [Abstract][Full Text] [Related]
13. Concurrent chemoradiotherapy with/without induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: Long-term results of phase 3 randomized controlled trial.
Li WF; Chen NY; Zhang N; Hu GQ; Xie FY; Sun Y; Chen XZ; Li JG; Zhu XD; Hu CS; Xu XY; Chen YY; Hu WH; Guo L; Mo HY; Chen L; Mao YP; Sun R; Ai P; Liang SB; Long GX; Zheng BM; Feng XL; Gong XC; Li L; Shen CY; Xu JY; Guo Y; Chen YM; Zhang F; Lin L; Tang LL; Liu MZ; Ma J; Sun Y
Int J Cancer; 2019 Jul; 145(1):295-305. PubMed ID: 30613964
[TBL] [Abstract][Full Text] [Related]
14. Establishment and validation of two nomograms to predict the benefit of concurrent chemotherapy in stage II-IVa nasopharyngeal carcinoma patients with different risk factors: Analysis based on a large cohort.
Sun XS; Xiao BB; Lin C; Liu SL; Chen QY; Tang LQ; Mai HQ
Cancer Med; 2020 Mar; 9(5):1661-1670. PubMed ID: 31925942
[TBL] [Abstract][Full Text] [Related]
15. Matched analysis of induction chemotherapy plus chemoradiotherapy versus induction chemotherapy plus radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a multicenter study.
Zhang B; Hu Y; Xiong RH; Pan YF; Xu QL; Kong XY; Cai R; Chen QQ; Tang HY; Jiang W
Oncotarget; 2017 Feb; 8(8):14078-14088. PubMed ID: 27845907
[TBL] [Abstract][Full Text] [Related]
16. MRI-Based Deep-Learning Model for Distant Metastasis-Free Survival in Locoregionally Advanced Nasopharyngeal Carcinoma.
Zhang L; Wu X; Liu J; Zhang B; Mo X; Chen Q; Fang J; Wang F; Li M; Chen Z; Liu S; Chen L; You J; Jin Z; Tang B; Dong D; Zhang S
J Magn Reson Imaging; 2021 Jan; 53(1):167-178. PubMed ID: 32776391
[TBL] [Abstract][Full Text] [Related]
17. Induction Chemotherapy plus Concurrent Chemoradiotherapy in Endemic Nasopharyngeal Carcinoma: Individual Patient Data Pooled Analysis of Four Randomized Trials.
Chen YP; Tang LL; Yang Q; Poh SS; Hui EP; Chan ATC; Ong WS; Tan T; Wee J; Li WF; Chen L; Ma BBY; Tong M; Tan SH; Cheah SL; Fong KW; Sommat K; Soong YL; Guo Y; Lin AH; Sun Y; Hong MH; Cao SM; Chen MY; Ma J
Clin Cancer Res; 2018 Apr; 24(8):1824-1833. PubMed ID: 29431618
[No Abstract] [Full Text] [Related]
18. A four-miRNA signature identified from genome-wide serum miRNA profiling predicts survival in patients with nasopharyngeal carcinoma.
Liu N; Cui RX; Sun Y; Guo R; Mao YP; Tang LL; Jiang W; Liu X; Cheng YK; He QM; Cho WC; Liu LZ; Li L; Ma J
Int J Cancer; 2014 Mar; 134(6):1359-68. PubMed ID: 23999999
[TBL] [Abstract][Full Text] [Related]
19. Prognostic nomogram for patients with Nasopharyngeal Carcinoma incorporating hematological biomarkers and clinical characteristics.
Li J; Chen S; Peng S; Liu Y; Xing S; He X; Chen H
Int J Biol Sci; 2018; 14(5):549-556. PubMed ID: 29805306
[TBL] [Abstract][Full Text] [Related]
20. Serum miRNAs, a potential prognosis marker of loco-regionally advanced nasopharyngeal carcinoma patients treated with CCRT.
Zhang Z; Huang J; Wang G; Jin F; Zheng J; Xiao H; Lei L; Luo J; Chen C
BMC Cancer; 2020 Mar; 20(1):183. PubMed ID: 32131777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
